Dune Medical Devices Receives FDA Approval for Breakthrough Advancement in Breast Cancer Surgery

MarginProbe® System over 3 times more effective in identifying "cancer on the margin" during lumpectomy than traditional intra-operative methods

Summary:

Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration.

Date: 02 January 2013, 15:15 PM EST
Source: Dune Medical Devices
Related Sites: http://www.dunemedical.com
Show/Hide more...

Social Media Tools:


Click asset titles for downloads, embeds and more...

Video

Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. Video
Click asset titles for downloads, embeds and more...

Photos

Full MarginProbe System
Full MarginProbe System
MarginProbe in Use
MarginProbe in Use
MarginProbe with Cable
MarginProbe with Cable

Subscribe via RSS

RSSAll Content
RSSConsumer
RSSEntertainment
RSSFinancial
RSSGovernment
RSSHealthcare
RSSRetail
RSSTechnology

Register

Journalists who register may create email subscriptions to search results and a cart of assets to download. Click here to login, register or edit profile.

What Our Users
Are Saying

"I like the way the DC is easy to navigate, easy to find stories, easy to find when they were filed so you know if they’re out of date, and easy to see an on-line version of the available video" -- Allan C Lee, Director of News and Current Affairs